| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Haemonetics Corp (HAE) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 29 sells. HAE is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 28.9K | $2.24M | - | |
| Dir | 25.0K | $1.93M | - | |
| Dir | 24.8K | $1.91M | - | |
| Dir | 19.4K | $1.50M | - | |
| Dir | 16.9K | $1.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2017 | Gelbman Ronald G | Director | Sale+OE | 8,580 | $40.00 | $343,200.00 | -14.7% | |
| Dec 12, 2016 | Gelbman Ronald G | Director | Sell | 5,683 | $40.30 | $229,024.90 | -10.3% | |
| Aug 17, 2016 | Merriman Ronald49 | Director | Sell | 4,337 | $35.14 | $152,398.44 | -1.4% | |
| Aug 5, 2016 | Foote Susan Bartlett | Director | Sale+OE | 14,685 | $35.35 | $519,105.45 | -9.7% | |
| Aug 4, 2016 | Simon, Christopher | President &CEO | Buy | 60,000 | $35.00 | $2,099,754.00 | +130.8% | |
| Oct 26, 2015 | Selman Byron | President, Global Markets | Sell | 344 | $32.13 | $11,052.41 | -2.8% | |
| Oct 26, 2015 | White Jonathan | Chief Science And Technology | Sell | 319 | $32.13 | $10,249.18 | -1.0% | |
| Oct 26, 2015 | Jesse Sandra | EVP And Chief Legal Officer | Sell | 778 | $32.13 | $24,996.44 | -3.7% | |
| Oct 26, 2015 | Hanlon Susan M | VP Finance | Sell | 497 | $32.13 | $15,968.16 | -2.4% | |
| Oct 26, 2015 | Lindop Christopher J | CFO &EVP Business Development | Sell | 436 | $32.13 | $14,008.29 | -1.0% |